首页> 外国专利> ANALYTICAL () METHOD FOR IDENTIFYING, DOSING ENROFLOXACINE AND CHEMICALLY RELATED IMPURIITIES IN THE PHARMACEUTICAL PRODUCT ENRODEM 10 - ORAL SOLUTION, ENRODEM 50-HYDROSOLUBLE POWDER AND ENROFLOXACINE HCL AS ACTIVE PHARMACEUTICAL INGREDIENT

ANALYTICAL () METHOD FOR IDENTIFYING, DOSING ENROFLOXACINE AND CHEMICALLY RELATED IMPURIITIES IN THE PHARMACEUTICAL PRODUCT ENRODEM 10 - ORAL SOLUTION, ENRODEM 50-HYDROSOLUBLE POWDER AND ENROFLOXACINE HCL AS ACTIVE PHARMACEUTICAL INGREDIENT

机译:鉴定,剂量为10%的医药产品中的恩诺沙星和化学相关杂质的分析()方法-口服溶液,ENRODEM 50水溶性粉末和恩洛沙星HCL作为活性药物成分

摘要

The invention relates to an analytical method of identifying and dosing enrofloxacine and the chemically related impurities. According to the invention, the method consists of the chromatography on an octadecylsyllyl silicagel column, at a temperature on the column of 40°C by using acetonitrile as movable phase: HPO25 mM and tetrahydrofuran, the column testing being performed by injecting a reference solution containing 3 ppm of enrofloxacine and 3 ppm of ciprofloxacine, with a concentration of 1000 ppm, at a number of minimum 2000 of theoretical plates for enrofloxacine and a resolution of minimum 1.5 between the peaks of the components, the recording time being of about 10 minutes, namely twice the enrofloxacine retention time.
机译:本发明涉及鉴别和定量恩诺沙星和化学相关杂质的分析方法。根据本发明,该方法包括在十八烷基甲硅烷基硅胶柱上在40℃的温度下通过使用乙腈作为可移动相:HPO25mM和四氢呋喃进行色谱法,通过注入包含恩诺沙星的理论板数最少为2000时,恩诺沙星的浓度为3 ppm,环丙沙星的浓度为3 ppm,最小浓度为1000 ppm,各组分峰之间的分辨率最小为1.5,记录时间约为10分钟,即恩诺沙星保留时间的两倍。

著录项

  • 公开/公告号RO126607A0

    专利类型

  • 公开/公告日2011-08-30

    原文格式PDF

  • 申请/专利权人 NEAGU MARIA;

    申请/专利号RO20100001145

  • 发明设计人 NEAGU MARIA;

    申请日2010-11-22

  • 分类号G01N30/02;

  • 国家 RO

  • 入库时间 2022-08-21 18:04:47

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号